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a b s t r a c t
Gro/TLE proteins (TLE1-4) are a family of transcriptional corepressors acting downstream of multiple
signalling pathways. Several TLEs are expressed in a dynamic manner throughout embryonic develop-
ment and at high levels in embryonic stem cells (ESCs). Here we ﬁnd that Gro/TLE is not required in ESC
for sustaining pluripotency and suppressing differentiation genes, but rather is important for the
shutting down of the pluripotency network in differentiation. Consistent with this view, we found that
one of the Gro/TLE family, TLE4 is expressed heterogeneously in ESCs in a population that corresponds to
a Nanog low subset of ESC culture. TLE4 expression is also increased in response to LIF withdrawal and
Fgf/Mek/Erk stimulation. To explore the role of Gro/TLE in more detail we generated an allelic series of
knockout ESCs of two TLE genes expressed most dynamically in early differentiation, TLE3 and TLE4.
Genetic reduction in TLE dose resulted in an increase in the expression of pluripotency markers and
inhibition of ESC differentiation towards both epiblast and endoderm lineages. Overexpression of a drug
inducible TLE4 could both rescue TLE3/TLE4 compound phenotypes and induce early expression of
endoderm (Hhex-Venus) and neural (Sox1-GFP) reporter genes. Taken together, our results suggest that
TLE activity is essential for early differentiation where it acts to suppress the pluripotency network,
allowing for the initiation of lineage speciﬁc gene expression programs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Embryonic stem cells (ESCs) are karyotypically normal immor-
tal cell lines derived from the mammalian blastocyst. Their two
deﬁning characteristics are that they are pluripotent, able to
differentiate into all the lineages of the future organism, and they
can propagate this potency through cell division, self-renewal. The
balance between self renewal and differentiation is controlled by a
combination of extrinsic signalling molecules and a complex
network of interacting transcription factors including Nanog,
Oct4, Sox2, Esrrb and Klf4 (Chambers and Tomlinson, 2009).
Extrinsic signalling that supports ESC self-renewal and blocks
differentiation includes the cytokine LIF, and the canonical Wnt
pathway (Cole et al., 2008; Ten Berge et al., 2011; Wray et al., 2011)
that acts to inhibit Tcf3 mediated repression and stimulate
transcription through Tcf1 (Shy et al., 2013; Wu et al., 2012; Yi
et al., 2011). In addition ESC differentiation can be suppressed by
inhibiting Fgf signalling with a small molecule inhibitor of
Mek/Erk, downstream of the receptor (Kunath et al., 2007; Nichols
et al., 2009). Deﬁned media including LIF, plus small molecule
inhibitors of Mek, and of Gsk3 that leads to the activation of
downstream Wnt components, enables effective derivation and
expansion of pluripotent ESCs under deﬁned conditions (Ying
et al., 2008).
Despite clonal origins and exposure to the same environment,
individual ESCs in a culture display differentially expressed genes
(Hayashi et al., 2008; Singh et al., 2007) and different develop-
mental competencies (Beddington and Robertson, 1989; Morgani
et al., 2013). This may reﬂect their embryonic origins from a stage
where the primitive endoderm (PE) and epiblast (Epi) are in the
process of being speciﬁed. Thus ES cell cultures contain at least
two populations of cells, with one primed towards embryonic and
the other PE differentiation (Canham et al., 2010; Davies et al.,
2013; Morgani et al., 2013). In the blastocyst, the intermediate step
in lineage segregation between PE and Epi is transient, but in ESCs
this heterogeneity is dynamic and subpopulations can interconvert
under conditions supporting self renewal (Canham et al., 2010;
Kobayashi et al., 2009). However, when blocks to differentiation
are removed, for example by withdrawing LIF or increasing Erk
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stimulation, ESCs become committed to either epiblast or PE
differentiation. Why cells can progress part way, primed to a
particular lineage within ESC culture but still retaining the ﬂex-
ibility to differentiate in other directions, is not understood.
Gro/TLE proteins are transcriptional corepressors expressed in
many cell types throughout development. The family is named for
the Drosophila Groucho originally identiﬁed as a suppressor of
Notch signalling. These proteins do not bind directly to DNA, but
are recruited via protein-protein interactions with a variety of
sequence speciﬁc DNA binding proteins including bHLH and Fox
family proteins, Tcf/LEF, Hhex and Runx1 (Buscarlet and Stifani,
2007; Jennings and Ish-Horowicz, 2008). When bound, they can
mediate local repression by a diverse set of mechanisms including
histone deacetylase (HDAC recruitment) (Chen et al., 1999) and
chromatin condensation via physical tethering of histone tails
(Sekiya and Zaret, 2007). There are 4 full-length, structurally
similar TLE family members in mammalian genomes (TLE1-4)
with different but overlapping expression patterns, indicating a
degree of functional redundancy. The two family members that are
expressed in ESCs and exhibit the most dynamic gene expression
patterns upon differentiation are TLE3 and TLE4 (Cloonan et al.,
2008), suggesting that the regulation of their levels may be crucial
for normal differentiation.
As ESC self renewal is dependent on activation of a canonical
Wnt signal that acts through beta-catenin to displace Gro/TLE
proteins from Tcf factors, and Tcf3 targets include most of the
pluripotency network, TLE proteins would appear potential keys to
regulating commitment to differentiation. They have been indir-
ectly implicated in the regulation of ESC self-renewal through
their direct interactionwith Tcf3 on the Nanog (Pereira et al., 2006)
and Oct4 (Tam et al., 2008) promoters. In addition, TLEs interact as
corepressors with proteins such as FoxD3 and Hes1, transcription
factors that have been implicated in regulating ESC differentiation
(Liu and Labosky, 2008; Zhou et al., 2013).
In this paper we explore the role of TLE proteins in early ESC
differentiation, focusing on the two family members with the most
cell type speciﬁc regulation, TLE3 and TLE4. We found that a TLE4
reporter is expressed heterogeneously in mouse ESCs and this
correlates with the Nanog low subpopulation. TLE4 expression
also increases upon LIF withdrawal and is regulated by the
heterogeneously expressed homeobox protein Hhex (Zamparini
et al., 2006). To explore the role of Gro/TLE in the earliest steps in
differentiation, we generated an allelic series of TLE3 and TLE4
mutant ESCs, plus drug inducible TLE4 expressing ESC lines and
show that loss of these genes leads to increased pluripotency
marker expression and inhibited ESC differentiation towards both
the epiblast and endoderm lineages. Taken together our data
support a model where Gro/TLE are required to silence the
expression of the pluripotency network in differentiation towards
multiple lineages.
Results
TLE4 is expressed heterogeneously in mouse ESCs
Several TLEs are expressed in ESCs; to understand whether this
represents ubiquitous expression or whether TLE marks a speciﬁc
lineage primed population, we generated reporter ESCs from
animals containing a TLE4ßgeo gene trap reporter (Fig. 1A)
(Friedel et al., 2005). Fig. 1B shows expression of the ßgeo reporter
to be heterogeneous in undifferentiated ESCs. Those cells that
expressed high levels of TLE4ßgeo also expressed low levels of the
pluripotency transcription factor Nanog (Fig. 1C). Although not all
Nanog low cells expressed high TLE4, the high TLE4 subpopulation
had consistently lower levels of Nanog (Fig. 1D). As there is
considerable heterogeneity in the Nanog low population,
increased TLE4 expression might mark the earliest reversible
stages of ESC differentiation or cells biased towards a particular
lineage (Martinez Arias and Brickman, 2011). As ESCs can be
readily differentiated by the withdrawal of LIF from the culture
medium, we assessed whether this heterogeneity was enhanced in
early differentiation and found TLE4 expression was signiﬁcantly
induced as an immediate early response to LIF removal (24 hLIF)
(Fig. 1B). However the extent of this induction declined at 48 h and
was reduced to þLIF levels at 72 h. This was conﬁrmed by qPCR
analysis of TLE4 (Fig S1A). This transient increase in TLE4 expres-
sion suggests that TLE4 may be involved in the earliest stages of
ESC differentiation. TLE1 also appears induced in LIF withdrawal,
TLE3 remains expressed at high levels in both ESCs and early
during differentiation and this overall increase in TLE activity is
consistent with the LIF/Stat dependent inhibition of AES/TLE5
expression, which sometimes acts as an antirepressor of full-
length TLE (Sekkai et al., 2005). As the Mek/Erk pathway is also
a regulator of early ESC differentiation (Cheng et al., 1998; Nichols
et al., 2009) we assessed its impact on TLE expression. Inclusion of
an inhibitor of Mek, PD0325901 (PD03) almost completely alle-
viated TLE4ßgeo expression (Fig. 1B), while exogenous FGF in
combination with the phosphatase inhibitor NaVO, to block
receptor tyrosine kinase dephosphorylation (Hamazaki et al.,
2006; Huyer et al., 1997), enhanced TLE4 expression(Fig S1B).
Thus TLE expression appears correlated with early steps in
differentiation.
Loss of TLE proteins enhances self-renewal ability of ESCs
To assess whether TLE proteins can regulate the exit from self-
renewal we generated ESCs mutants for TLE activity. RNAseq and
microarray data shows TLE3 and TLE4 are the highest and most
dynamically expressed members of this family and are both
upregulated in EB differentiation (Cloonan et al., 2008; Ramahlo-
Santos et al., 2002). In addition the NCBI Unigene database
suggests that TLE3 and TLE4 are the highest expressed full-length
TLE genes in morula and blastocyst stage mouse embryos. More-
over, we had previously identiﬁed TLE4, and possibly TLE3, as
targets of the early endoderm factor Hhex (Zamparini et al., 2006).
As both TLEs are expressed in ESCs and are highly conserved, they
are potentially redundant and as a result, we inactivated both
genes. TLE4ßgeo/ßgeo ESCs were derived from the TLE4þ /ßgeo mice
and the TLE3 gene mutated using homologous recombination by
inserting a promoterless gene trap vector into intron 4 of the TLE3
locus (Figs. 1E and S2A). The position of this gene trap insertion is
similar to the previous insertion in the TLE4 locus, introducing a
stop codon early in the coding sequence so that only a truncated N
terminal fragment with no predicted function was expressed. The
targeting vector contained an mOrange reporter, a synthetic poly-
A/C2MAZ sequence to terminate downstream transcription and
translation, and a removable selection cassette ﬂanked by LoxP
sites. Excision of the selection cassette following Cre mediated
recombination allowed targeting of the second TLE3 allele to
generate both TLE4 / TLE3þ / and TLE4/ TLE3 / ES cell
lines. Targeting was conﬁrmed at both stages by PCR genotyping
(Fig S2B and C) and loss of wild type TLE3 and TLE4 mRNA
conﬁrmed by qRT-PCR (Fig S2D). TLE4þ /ßgeo and TLE4ßgeo/ßgeo ESCs
were karyotypically normal. Following the second round of gene
targeting, we conﬁrmed that TLE4/ TLE3/ ESCs maintained a
normal karyotype indicating no chromosomal abnormalities had
been introduced at any stage of the targeting (Fig S2E). However,
mOrange ﬂuorescence was undetectable by optical methods
despite the transcript being expressed, possibly due to insufﬁcient
protein concentration (data not shown). A subclone of TLE4 /
TLE3 / ESCs was also generated, containing a human TLE1
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(hTLE1) expression construct (Fig. 1F). This allowed us to test
whether any phenotype caused by lost TLE3 and TLE4 could be
rescued by another TLE protein. All insertions, reporter and
expression constructs and cell lines are illustrated schematically
in Fig S3.
The self-renewal ability of the TLE3/TLE4 mutant cells was
found to be enhanced based on the capacity of these cell lines
for clonal expansion (Fig. 2A and B). In the presence of LIF,
heterozygous TLE4þ / ESCs produced a mixture of colonies, with
normal undifferentiated tissue non-speciﬁc alkaline phosphatase
Fig. 1. TLE4 expression in ES cells and development of reagents for the functional study of these proteins. (A) Diagram of the TLE4-ßgeo targeted gene trap construct and its
genomic insertion site used by Friedel et al. to generate the transgenic mice used in this study. (B) X-gal staining showing the expression of TLE4 in TLE4þ /ßgeo ES cells in LIF/
serum, after LIF withdrawal for 24, 48 and 72 h and after 24 h addition of PD03. No X-gal staining was observed in E14 control cells treated identically. (C) Immunostaining
showing the mutually exclusive pattern of high Nanog and high TLE4-ßgeo in TLE4þ /ßgeo ES cells. Cells that express high levels of TLE4ßgeo express consistently lower levels
of Nanog. (D) Plot showing the mean Nanog and LacZ ﬂuorescence intensities for all individual DAPI positive nuclei imaged (n¼1872) measured using ImageJ. Median Nanog
ﬂuorescence (whole population)¼26.31. Median Nanog ﬂuorescence (cells expressing 43-fold of median TLE4ßgeo ﬂuorescence)¼16.89. (E) Diagram of the TLE3-mOrange
gene trap construct used to target TLE4ßgeo/ßgeo ES cells in order to generate TLE3þ /or/TLE4ßgeo/ßgeo and TLE3or/or/TLE4ßgeo/ßgeo (TLE3/TLE4 null) cell lines. (F) Diagram of the
expression construct used to rescue loss of TLE3/TLE4 in ESCs using human TLE1.
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Fig. 2. TLE activity is critical in allowing differentiation of ES cells and its loss correlates with an increase in self-renewal markers. (A) Colony forming ability of ES cells with reduced
TLE3/TLE4 activity. Cells were seeded at low density (50/cm2) and allowed to form colonies for 5d in the presence or absence of LIF. Colonies were then scored for positive alkaline
phosphatase staining and a tight, epithelial morphology. Percentages of AP positive undifferentiated colonies and those with an AP negative or mixed phenotype are shown.
(B) Images of representative AP stained colonies are shown for each cell line in the allelic series. (C) Immunostaining of Oct4 and Nanog expression in the TLE3/TLE4 allelic series
and the hTLE1 rescued line. (D) Quantiﬁcation of self-renewal (Oct4, Rex1, Nanog, Klf4 and Dppa3) and differentiation (TBra) markers in the TLE3/TLE4 allelic series by qPCR.
Expression levels were normalized with TBP and shown relative to those in TLE4þ / cells. Data shown is the mean of 2 independent experiments þ/ SD.
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(AP) positive cells surrounded by differentiated cells at the
periphery, plus fully AP positive (undifferentiated) and differen-
tiated AP negative colonies (Fig. 2B). The percentage of single ESCs
giving rise to undifferentiated ESC colonies with tight epithelial
morphology in control TLE4þ / and the single TLE4 / mutants
was 44% (inset shows examples of each colony type scored). In
contrast, 84% of TLE4/ TLE3þ / and 94% of TLE4/ TLE3 /
ESCs were able to form fully AP positive colonies. The enhanced
self-renewal of the TLE3/TLE4 double mutants was even more
pronounced when cells were allowed to differentiate as a result of
removing LIF from the culture medium. 64% of single ESCs from
the TLE4 / TLE3þ / and TLE4 / TLE3 / mutants were still able
to self renew and form undifferentiated AP positive colonies,
whereas only 5% of the control TLE4þ / were. Constitutive hTLE1
expression was able to partially rescue the mutant phenotype,
reducing the extent to which TLE4 / TLE3 / mutants were able
to self renew. In addition, TLE4/ TLE3 / mutants could be
maintained in GMEM without LIF for at least 10 passages with no
apparent morphological changes or loss of viability (data not
shown).
TLE4 / TLE3 / mutant ESCs also exhibit enhanced expres-
sion of core members of the pluripotency network. Based on
immunoﬂuorescence, both the homogeneity and expression of
Oct4 and Nanog were enhanced in TLE4 / TLE3 / ESCs (Fig. 2C)
and this enhanced expression was suppressed by rescue with
hTLE1 expression. ESC gene expression was also assessed by qPCR
for cells grown in either the presence or absence of LIF (Fig. 2D).
Oct4, Nanog, Klf4, Rex1 and Dppa3 transcripts were all higher in
TLE4 / TLE3þ / and TLE4 / TLE3 / ESCs than TLE4þ / and
TLE4 / cells. In contrast the early epiblast and mesoderm marker
TBra, which is normally induced early in ESC differentiation in
response to LIF withdrawal, is suppressed by reduced TLE dosage.
Thus despite the robust expression of TLEs in ESCs, they do not
appear to have a repressive effect on this speciﬁc marker. This
appears to be the case for markers of other lineages as well, as the
TLE4 / TLE3 / ESCs express lower levels of early differentiation
genes than control cell lines, including neural (Nestin, Fig. 4B) and
endodermal (Gata6, Bmp2 and Dab2, Fig. 4C) genes. We also
conﬁrmed that a second, separate TLE4 / TLE3 / clone (G12)
also exhibited the same phenotype (Fig S4).
To further investigate the basis for this phenotype a drug
activatable TLE4 protein was constructed by fusing a mutant
version of the ligand-binding domain of the estrogen receptor
(ERT2) to the intact coding sequence of mouse TLE4 to make
ERT2–TLE4. This fusion protein was then introduced downstream
of a CAG driven GFP, separated by a cleavable T2A peptide, but
upstream of an IRES Puro to make CAG GFP ERT2-TLE4 IRES Puro
(Fig. 3A). The generation of this tripartite cistron ensures that GFP
and Puro are expressed in the same cells as ERT2–TLE4. We ﬁrst
conﬁrmed that ERT2–TLE4 was inducible by the estrogen analogue
4-hydroxytamoxifen (4OHT). As TLE4 is a repressor of Wnt
signalling, it is able to represses transcription of a Wnt reporter
that contains binding sites for the Tcf transcription factor driving
luciferase expression in transient transfections (TOP ﬂash). Fig. S5
shows that ERT2–TLE4 was able to repress Wnt reporter transcrip-
tion, but only in the presence of 4OHT. TLE4 / TLE3 / ESCs were
then electroporated with ERT2–TLE4, selected in antibiotic and
subclones stably and homogeneously expressing GFP identiﬁed.
ERT2–TLE4 expressing cells responded in a dose dependent
manner to 4OHT in a colony-forming assay and became increas-
ingly less AP positive as 4OHT concentration increased (Fig. 3B).
Parental cells showed no response to the drug. Addition of 4OHT
also reduced Oct4 and Nanog protein levels in these cells (Fig. 3C).
To further study downstream effects of TLE activity loss that
could be contributing to this phenotype, we used this system to
look for pluripotency-associated transcripts that responded to
TLE4 re-expression in a TLE3/TLE4 null background. Dppa3 was
the most responsive gene tested and was reduced by around 45%
within 24 h of drug addition (Fig. 3D). Nanog also showed a more
modest reduction of around 19% and further declined to a 35%
drop by d3. Nanog and Dppa3 are located in the same genomic
locus and exhibit coregulation by chromatin modiﬁcation
(Levasseur et al., 2008). Rex1 was also inhibited but not until d2,
and Oct4 remains unchanged.
Many of these markers are also repressed targets of Tcf3 in
ESCs, which has been shown to be a downstream target of the self-
renewal promoting effect of GSK3 inhibition, and uses TLE as a
corepressor. GSK3 inhibition by the small-molecule inhibitor
CHIRON99021 is used in the 2i deﬁned media culture system, in
conjunction with Mek/Erk inhibition plus LIF to sustain self-
renewal (Ying et al., 2008). Therefore we tested whether CHIRON
inhibition was necessary to sustain TLE mutant ESCs (Fig S6). There
was little difference in Oct4 levels and cell morphology between
control and TLE3/TLE4 mutant ESCs in standard 2i/LIF. However
when CHIRON was removed, TLE4 single mutant ESCs could not be
maintained past 2 passages whereas TLE4 / TLE3/ ESCs
maintained a viable, Oct4 positive state. This is similar to the
phenotype of Tcf3 / ESCs (Yi et al., 2011) and suggests TLE may
be a vital component in its regulation of the pluripotency network.
TLE mutant ESCs fail to differentiate efﬁciently to the primitive
endoderm and neural lineages
The TLE homologue Grouchowas ﬁrst identiﬁed as a suppressor
of neural identity in drosophila ectoderm and also found to
regulate post-mitotic neuron maturation in mammals (Yao et al.,
2000; Ziemer et al., 1988). We therefore looked at whether
mutation of TLEs would affect ESC differentiation to the neural
lineage. As ESCs will differentiate readily to neurons when plated
in N2B27 neurobasal media in the absence of cytokines or
inhibitors (Ying et al., 2003) we used these conditions to test the
efﬁciency of neural differentiation in TLE4 / TLE3 / ESCs.
Fig. 4A shows that wild type E14 ESCs generated large numbers
of ß (III) tubulin (TujI) positive neurons. While TLE4 mutant cells
also made neurons, the numbers of neurons produced were
somewhat reduced (data not shown). However, the compound
TLE3/TLE4mutant lines did not produce any TujI positive cells with
neuronal morphology. Oct4 expression was also maintained exten-
sively throughout TLE3/TLE4 double mutant cultures while those
of wild-type ESCs and single TLE4 mutants had only limited,
differentiation resistant foci. Constitutive expression of TLE1 in
TLE3/TLE4 null cells proved unable to rescue the block to differ-
entiation. We conﬁrmed the block to neural differentiation by qRT-
PCR for the early neurectoderm marker Nestin and the later neural
precursor marker BLBP (Fig. 4B) during differentiation. BLBP was
strongly expressed in both TLE4þ / and TLE4 / cultures by the
end of the protocol but almost completely absent from TLE4 /
TLE3 / cultures. TLE4þ / cells also expressed more Nestin at d3
and d5 than the other mutants. This suggests that the block to
neural differentiation is occurring at an early stage and may be
caused by the inhibited downregulation of pluripotency markers
such as Oct4.
A general failure to down regulate pluripotency factors should
also affect differentiation in other lineages and so we explored the
capacity of TLE4 / TLE3 / ESCs to generate primitive endoderm.
In vivo, the primitive endoderm (PE) is formed in the inner cell
mass (ICM) of the blastocyst as a result of Fgf/Mek/Erk signalling
promoting the upregulation of Gata6 and downregulation of
Nanog. ESCs also contain a PE precursor population that can be
expanded in response to FGF signalling. As TLE4 expression in ESCs
is dependent on Mek, we asked whether it is required to mediate
the Mek/Erk response. PE differentiation can be induced in vitro by
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stimulating Mek/Erk using the phosphatase inhibitor sodium
vanadate on ESC embryoid body (EB) aggregates (Hamazaki et
al., 2006). When TLE4/ TLE3 / and E14 ESCs were differen-
tiated toward PE under these conditions, the PE markers Gata6 and
Bmp2 increased in the control cells, but not the mutants after
NaVO stimulation (Fig. 4C). While the PE marker Dab2 increased in
EBs formed from both cell lines, the overall levels of Dab2
were lower in TLE4 / TLE3 / cells. Moreover basal level
expression of both Dab2 and Gata6 in ESC culture was also lower
in TLE4 / TLE3/ mutants. Consistent with the increased Gata6
expression, Nanog was downregulated in E14 aggregates and
this was further ampliﬁed by Mek/Erk stimulation. The TLE4 /
TLE3 / aggregates also failed to downregulate Nanog or upregu-
late Gata6 and Bmp2 in response to Mek/Erk stimulation.
As TLE loss-of-function inhibited differentiation towards both
neural and PE lineages, we also wanted to test whether TLE
overexpression would increase differentiation towards these
lineages. We used a modiﬁed version of the tamoxifen inducible
TLE4 vector, ERT2–TLE4 in which the GFP marker was replaced
with mCherry, and generated ERT2–TLE4 inducible over expres-
sion in speciﬁc lineage reporting ESC lines. We employed two
different ﬂuorescent reporter cell lines: a sensitive reporter for the
early endoderm marker HHex (Hex-gtxIRES-Venus, HIV 5.1) that
is expressed in both early endoderm and uncommitted PE
Fig. 3. Inducible activation of TLE4. (A) Diagram of tamoxifen inducible TLE4 expression construct (ERT2–TLE4). (B) Colony forming ability of TLE3/TLE4 mutant ES cells after
TLE4 activity is rescued by ERT2–TLE4 induction. Cells were grown at in GMEM/LIF, þ/4OHT (0, 100, 500 or 1000 nM) at a plating density of 50/cm2 and colonies were
stained for alkaline phosphatase activity after 5d and scored as fully undifferentiated (all AP positive) or mixed/differentiated in nature. Percentages of each type are shown
as a mean of 2 independent experiments. (C) Immunostaining of TLE4 rescued cells showing downregulation of Nanog and Oct4 after TLE4 induction by 4OHT for 3d.
(D) TLE4 was induced in ERT2–TLE4 rescued TLE4/ TLE3/ cells and its immediate effects on self-renewal markers (Dppa3, Nanog, Oct4 and Rex1) examined by qPCR at
different timepoints (dark bars). The parental cell line (TLE4 / TLE3/) with no inducible TLE4 was also assayed as a comparison (light bars). No signiﬁcant changes were
observed with addition of the drug solvent (ethanol 0.01%) alone. Expression values were normalized with TBP and shown relative to TLE4/ TLE3/ cells without 4OHT.
Data is the mean of 2 independent experiments þ/ SD.
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Fig. 4. TLE3/TLE4 null cells fail to differentiate efﬁciently to neural and primitive endoderm lineages. (A) Cells from the allelic series of TLE3/TLE4 mutants were
differentiated towards the neural lineage in a monolayer protocol with N2B27 media for 7d. Immunostaining was performed for Oct4 and Tuj1 to mark undifferentiated and
neuronal cells. (B) TLE mutant cells were differentiated in the same neural protocol and analysed at different timepoints by qPCR for the neural markers Nestin and BLBP.
(C) E14 wt and TLE4/ TLE3/ ESCs were differentiated towards primitive endoderm as embryoid bodies for 48 h with or without sodium vanadate (NaVO). Nanog and the
PE markers Gata6, Bmp2 and Dab2 were analysed by qPCR from ESCs and differentiated EBs. Expression levels were normalized with TBP. Data shown is the mean of
2 independent experiments þ/ SD. (D) ERT2–TLE4 was induced by 4OHT (þT) in Hex-Venus reporter ES cells (HIV TLE4) and the Venus reporter assayed by ﬂow cytometry
after 3d. TLE4 induction by 4OHT caused an increase in Hex-Venusþ cells not seen in the parental line (HIV 5.1). (E) ERT2–TLE4 was induced by 4OHT (þT) in 46c Sox1 GFP
reporter ES cells (46c TLE4) for 3d of neural induction. TLE4 induction causes an increase in Sox1þ cells not seen in the parental line (46c). Data shown is the mean of
3 independent experiments.* Indicates statistically signiﬁcant (po0.01) difference between treated and untreated samples.
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precursors in ESC cultures (Canham et al., 2010) and one that
marks neural progenitors, a Sox1-GFP (46C) (Ying et al., 2003).
Activation of TLE4 in both reporters led to a modest but statisti-
cally signiﬁcant increase in the population of differentiating cells.
In ESCs, the addition of 4OHT led to an increase in the Venus
positive population of PE primed cells (Fig. 4D), whereas the
administration of 4OHT to neurobasal media lead to increase in
the percentage of Sox1-GFP cells three days into differentiation
(Fig. 4E). Thus both gain and loss of function models for Gro/TLE
activity indicate that these proteins promote differentiation
towards multiple lineages, presumably by enabling the repression
of the gene regulatory networks associated with the ESC state.
Discussion
In this paper we have shown that Gro/TLE proteins are
expressed in ESC and particularly the early stages of ESC differ-
entiation. The removal of TLE activity through the generation of
compound mutants did not result in enhanced lineage speciﬁc
gene expression in ESCs, but in enhanced self-renewal and a block
to differentiation, whereas the overexpression of TLE proteins
promote the expansion of differentiating populations. Taken
together our data support a model where Gro/TLEs act in con-
junction with sequence speciﬁc DNA binding protein partners to
repress the ESC transcription factor network and mediate differ-
entiation toward multiple lineages (Fig. 5).
One of the central members of the ESC transcription factor
network is Tcf3, a member of the Tcf/Lef family of transcription
factors known to interact with Gro/TLE proteins. Tcf3 acts as a
repressor when bound by TLE in the absence of Wnt pathway
activation. Wnt signalling, or inhibition of downstream GSK3
stabilizes cytoplasmic ß-catenin which binds activator forms of
Tcf/Lef e.g. Tcf1, to displace TLE/Tcf3 and activate Wnt target genes
in the nucleus (Chodaparambil et al., 2014; Yi et al., 2011). The
default activity of Tcf3 as a repressor in conjunction with TLE is
supported by its activity in hair-follicle stem cells where it acts
solely as a repressor to preserve quiescence. In the absence of
depression by β-catenin, during activation of hair regeneration,
1938 of the 3387 Tcf3 targets are also bound by TLE proteins. There
is also signiﬁcant overlap between Tcf3 targets in these cells and
ESCs, and this overlap contains canonical Wnt targets such as
Axin2 and TLE4 itself (Lien et al., 2014). Tcf3 is also known to bind
a host of ESC speciﬁc transcription factor promoters including
Nanog, Rex1, Dppa3, Oct4, Sox2 and Essrb (Cole et al., 2008;
Martello et al., 2012; Yi et al., 2008). This correlation between
Tcf3 targets and members of the pluripotency network is further
supported by global assessments of Tcf3 binding in ESC (Cole et al.,
2008; Marson et al., 2008). Thus, for example, of 1369 Tcf3 targets
in ES cells identiﬁed by ChIP seq, 942 were also co-occupied by
Oct4, Sox2 and Nanog protein including many pluripotency factors
such as Nanog, Oct4 Dppa3, Tcfcp2l1 and Nr0b1 (Marson et al.,
2008). Another TLE, TLE2 was also found to be bound in conjunc-
tion with Tcf3, but not ß-catenin at the Oct4 promoter in ESCs,
suggesting a role for TLE proteins in mediating the suppression of
pluripotent gene expression via Tcf3 (Tam et al., 2008). Taken
together, these observations suggest that Tcf3 may be one of the
principle means by which TLEs suppresses the pluripotency net-
work in differentiation, but we cannot exclude the importance of
the array of homeobox and WRPW containing transcription factors
expressed in early ESC differentiation.
It was recently demonstrated that ESCs could be maintained in
LIF and two small molecule inhibitors, the GSK3 inhibitor
CHIRON99021 and the Mek/Erk inhibitor PD03 (2i/LIF) (Ying et
al., 2008). The role of Chiron in 2i/Lif is purported to be the
derepression of Tcf3 mediated repression (Wray et al., 2011). Our
ﬁndings with respect to Gro/TLE are consistent with this view,
showing an effect on Tcf3 targets and the reduced dependence of
TLE mutant cells on the CHIRON component of 2i.
In addition, 2i contains a Mek/Erk inhibitor, PD03. Evidence
supports Nanog regulation being downstream of Mek/Erk signal-
ling as genetic ablation or inhibition of the pathway in embryos
leads to more widespread expression of Nanog (Chazaud et al.,
2006; Nichols et al., 2009). Our data suggest that TLE may be an
important component in suppressing Nanog in response to Mek/
Erk signalling. Thus Gro/TLE may be a potential direct target of Fgf/
Mek/Erk signaling that then suppresses pluripotency. Stimulation
by this pathway towards PE is also less efﬁcient in TLE3/TLE4
mutant cells. A number of Erk suppressed targets in ESCs such as
Nanog, Klf4 and Tbx3 (Hamilton et al., 2013) are also on a list of
Tcf3 targets (Marson et al., 2008).
As differentiation progresses and lineage specifying factors
become expressed, Gro/TLE is likely to play a further role. Many
lineage specifying transcription factors, such as homeobox pro-
teins, have been shown to recruit TLE via Eh1 and WRPW motifs.
Hhex requires TLE as a corepressor (Swingler et al., 2004) although
we also previously identiﬁed TLE4 as a suppressed target of Hhex
in ESCs (Zamparini et al., 2006) suggesting a more complex level of
interaction between the two. Interestingly we ﬁnd here that TLE4
expression increases the population of ESCs expressing a low level
of Hhex. This population expresses lower levels of epiblast and
pluripotency network members, suggesting that TLE may indir-
ectly stimulate the induction of PE priming as a result of down
regulating the pluripotency network. Lineage priming in ESCs is
inﬂuenced by another heterogeneously expressed factor, Hes1
(Kobayashi et al., 2009), which also interacts with TLE as a
corepressor.
Historically the role of Gro/TLEs has been very difﬁcult to study.
There are multiple family members with likely functional redun-
dancy, plus they are corepressors acting in conjunction with
multiple transcription factors, which also have their own changing
Pluripotency network (Nanog, Klf4, Dppa3, Oct4 etc)
TLE + DNA binding 
partners e.g. TCF3
FgfLIF
Pr
PE
Pr
Epi
PE
Epi
Self renewal
Neurectoderm
Fig. 5. Model for the role of TLE proteins in ESC differentiation. TLE proteins act to
repress pluripotency network members such as Oct4 and Nanog in conjunction
with DNA binding protein partners. TLE4 expression is increased by LIF withdrawal
and Fgf/Mek/Erk pathway stimulation to help propagate their downstream effects
on the pluripotency network. This facilitates ESC transition from a self-renewal
equilibrium containing primed epiblast (PrEpi) and primed PE (PrPE) precursors to
committed differentiation.
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expression. Despite the seemingly ubiquitous function of these
proteins, they are expressed in highly dynamic patterns in early
development. If they all have identical activity why the precise
expression patterns? Our study suggests that the dose of TLE/Gro
maybe very important and that a combination of two TLEs are
minimally required for early steps in differentiation. However
TLE3/TLE4 mutant cells can still differentiate, albeit with greater
difﬁculty, so a role for TLE1 cannot be ruled out. We observed the
effects of TLE level perturbation were greatest when ESCs were
challenged to differentiate, and that therefore TLE probably plays a
facilitative rather than an inductive role in differentiation. As
result, perhaps TLE acts as a bolt to lock away the pluripotent
state allowing ESCs to efﬁciently progress into differentiation.
Experimental procedures
LacZ staining of cells
Cells were washed in PBS and ﬁxed with X-gal ﬁx buffer (PBS,
0.1 M phosphate, 5 mM EGTA, 2 mM MgCl2, 0.2% gluteraldehyde)
for 20 min. They were then washed/permeabilised in rinse buffer
(100 mM sodium phosphate, 2 mM MgCl2, 0.01% sodium deox-
ycholate, 0.2% NP-40) for 320 min and stained (5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, 1 mg/ml X-gal (Pro-
mega) in rinse buffer) overnight at 37 1C. After washing 3 in PBS,
plates were stored and imaged in 70% ethanol. Imaging was
performed using an Olympus IX51 inverted microscope with
colour camera and Volocity (PerkinElmer) software.
Immunocytochemistry
Cells were washed with PBS and ﬁxed with 4% paraformalde-
hyde in PBS for 20 min. After 2 brief rinses in PBS, cells were
permeabilised in PBST (PBS, 0.1% Triton X-100) for 30 min and
blocked using 1% BSA and 3% serum (from secondary antibody
host species) in PBST for 30 min. Staining was performed in this
blocking solution O/N at 41. Primary antibodies used were: anti-
Nanog (mouse, eBiosciences), anti Oct3/4 (mouse IgG2a, Santa
Cruz), anti-ß (III) tubulin/TujI (mouse IgG2b, Covance) and anti-
ßgalactosidase (mouse, Promega). Appropriate AlexaFluor (Invi-
trogen) secondary antibodies were used. Cells were washed in
PBST after staining and imaged in PBS with DAPI. Imaging was
carried out using an Olympus IX51 inverted ﬂuorescence micro-
scope and Volocity software.
Colony forming assays and alkaline phosphatase staining
ES cells were plated at a density of 50/cm2 and grown in the
presence or absence of LIF for 5d to allow colony formation. They
were then ﬁxed and stained using the Alkaline Phosphatase Kit
(Sigma) according to the manufacturers protocol. Colonies were
counted and scored by morphology and level of AP staining, and
imaged using a Leica dissecting microscope. Colony type percen-
tages are an average of 3 experimental replicates.
Flow cytometry
Cultures were dissociated to single cell suspension by incuba-
tion in 0.1% trypsin followed by repeated pipetting, then washed
and resuspended in FACS buffer (PBS, 10% FCS). Propidium iodide
was added as a dead cell exclusion marker and the cells were
analysed on a FACSCalibur ﬂow cytometer with CellQuest software
(BD biosciences). Statistical data are from an average of at least
3 individual experiments.
Gene expression analysis
Total RNA was extracted from cells using an RNeasy kit
(Quiagen) and 500 ng used for cDNA synthesis using the Quanti-
Tect reverse transcription kit (Quiagen). qPCR analysis was per-
formed using SYBR green on an LC480 real-time PCR machine
(Roche). Samples were analysed in technical triplicate and normal-
ized using TBP transcript. Primers are listed in Table ST1.
ESC culture and manipulation
ESCs were maintained on gelatine coated plastic in GMEM with
LIF and 10% serum as standard. Monolayer neural differentiation
was performed according to (Ying et al., 2003). For experiments
using 4-hydroxytamoxifen in serum free media, BSA was added at
10 mg/ml to protect cell viability (Khar and Ali, 1987). LIF with-
drawal was performed according to (Fujikura et al., 2002).
PD0325901 and 4-hydroxytamoxifen were both used at 1 mM. 2i
culture was N2B27 with LIF and 1 mM PD0325901 plus or minus
3 mM CHIRON99021. Cells were plated in 2i at identical densities
and passaged 1:7 every 2d. Hanging drop embryoid body forma-
tion was performed according to (Hamazaki et al., 2006) in LIF free
media with Na3VO4 added at 25 mM.
Generation of constructs and cell lines
The TLE3 targeted gene trap was generated using homology
arms from pTTO-Grg3 (Friedel et al., 2005). Brieﬂy, a fragment
containing a hygromycin resistance/thymadine kinase (HygroTK)
positive/negative selection gene and poly-A was subcloned down-
stream of a splice acceptor from the pGT1 gene trap. A separate
plasmid containing the C2MAZ/synthetic-polyA transcriptional/
translational terminator subcloned downstream of the mOrange
ﬂuorescent protein sequence was generated and these were
inserted downstream of the HygroTK sequence in the ﬁrst plasmid.
Fragments encoding LoxP-t2a in the correct reading frame
between the 50 and 30 sequences were generated by overlapping
extension PCR and inserted between the splice acceptor/HygroTK-
pA and HygroTK-pA/mOrange junctions. The ﬁnished construct
was subcloned into the homology arms as an AscI fragment.
TLE4þ /ßgeo mice generated from pTTO-Grg4 ES cells (Friedel et
al., 2005) were kind gift from S. McConnell. Mice were outcrossed
from Bl6 onto a 129Sv background for 2 generations before ES cell
lines were derived from blastocyst outgrowths. Heterogeneous
and homogenous clones were identiﬁed by PCR genotyping using
the primers in Table ST2. The TLE3 locus of TLE4ßgeo/ßgeo cells was
targeted using 2 rounds of electroporation, antibiotic selection and
HygroTK cassette removal by Cre recombinase to ﬁrst generate
TLE4 / TLE3þ / and then TLE4 / TLE3 / cells. Correctly
targeted clones were identiﬁed at each stage using PCR genotyping
(primers in Table ST2), rtPCR to check gene trap splicing to the
upstream exon of TLE3 and qPCR analysis to conﬁrm loss of
targeted gene expression.
The CAGIPC-TLE1 construct used to rescue TLE4/ TLE3 /
cells was made from the human TLE1 cDNA subcloned down-
stream of the CAG promoter in a vector containing CAG-IRES-
PuroCherry-ﬂox-GFP. The tamoxifen inducible ERT2-TLE4 vectors
were made using overlapping extension PCR to fuse the ERT2
receptor and TLE4 in frame together and add the T2A and FLAG
epitope sequences 50 of ERT2. This was subcloned in frame
downstream of GFP and the complete GFP-T2A-FLAG-ERT2-TLE4
cassette inserted into a CAG-IRES-Puro promoter vector 30 of the
CAG. GFP containing ERT2-TLE4 vector was used to transfect
TLE4 / TLE3 / ESCs. The ERT2-TLE4 vector with mCherry
subcloned in place of GFP was electroporated into HIV 5.1 Hex-
Venus reporter (Canham et al., 2010) and 46c Sox1-GFP reporter
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(Ying et al., 2003) ESCs. After puromycin selection, clones stably
and homogeneously expressing high GFP or mCherry marker were
selected for analysis.
Luciferase reporter assay
HEK293 cells were transfected using Lipofectamine 2000
(Invitrogen) with SV40 Renilla luciferase (transfection efﬁciency
control), Super8 TOPﬂash (gift from R. Moon), CMV-ß catenin and
ERT2-TLE4. 4OHT was used at 1 mM. Luciferase activity was
analysed on a luminometer after 48 h using the Dual Luciferase
kit (Promega). Activity values are an average of 3 technical
replicates normalized to Renilla.
Acknowledgements
We thank Rosa Portero, Olivia Rodrigues, Jonathan Rans and
Janice Ure for technical assistance. Susan McConnell kindly pro-
vided the TLE4ßgeo mice and the TLE3 and TLE4 targeting vectors.
We are grateful to Randy Moon for plasmids, Stefano Stifani for
plasmids and critical discussions, and Alexi Sharov for help with
dataset analysis. This work was supported by the BBSRC (BB/
H005978/1). SL is a Wellcome Trust senior fellow. JMB was a MRC
senior non-clinical fellow and is supported by the Novo Nordisk
section for basic stem cell biology.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.10.007.
References
Beddington, R., Robertson, E., 1989. An assessment of the developmental potential
of embryonic stem cells in the midgestation mouse embryo. Development 105,
733–737.
Buscarlet, M., Stifani, S., 2007. The “Marx”of Groucho on development and disease.
Trends Cell Biol. 17, 353–361. http://dx.doi.org/10.1016/j.tcb.2007.07.002.
Canham, M., Sharov, A., Ko, M., Brickman, J., 2010. Functional heterogeneity of
embryonic stem cells revealed through translational ampliﬁcation of an early
endodermal transcript. PLoS Biol. 8, e1000379. http://dx.doi.org/10.1371/jour-
nal.pbio.1000379.
Chambers, I., Tomlinson, S., 2009. The transcriptional foundation of pluripotency.
Development 136, 2311–2322.
Chazaud, C., Yamanaka, Y., Pawson, T., Rossant, J., 2006. Early lineage segregation
between epiblast and primitive endoderm in mouse blastocysts through the
Grb2-MAPK pathway. Dev. Cell 10, 615–624.
Chen, G., Fernandez, J., Mische, S., Courey, A.J., 1999. A functional interaction
between the histone deacetylase Rpd3 and the corepressor groucho in
Drosophila development. Genes Dev. 13, 2218–2230.
Cheng, A.M., Saxton, T.M., Sakai, R., Kulkarni, S., Mbamalu, G., W, V., Tortorice, C.,
Cardiff, R.D., Cross, J.C., Muller, W.J., Pawson, T., 1998. Mammalian Grb2
regulates multiple steps in embryonic development and malignant transforma-
tion. Cell 95, 793–803.
Chodaparambil, J. V, Pate, K.T., Hepler, M.R., Tsai, B.P., Muthurajan, U.M., Luger, K.,
Waterman, M.L., Weis, W.I., 2014. Molecular functions of the TLE tetrameriza-
tion domain in Wnt target gene repression. EMBO J. 33, 719–731.
Cloonan, N., Forrest, A.R., Kolle, G., Gardiner, B.B., Faulkner, G.J., Brown, M.K., Taylor,
D.F., Steptoe, A.L., Wani, S., Bethel, G., Robertson, A.J., Perkins, A.C., Bruce, S.J.,
Lee, C.C., Ranade, S.S., Peckham, H.E., Manning, J.M., McKernan, K.J., Grimmond,
S.M., 2008. Stem cell transcriptome proﬁling via massive-scale mRNA sequen-
cing. Nat. Methods 5, 613–619.
Cole, M.F., Johnstone, S.E., Newman, J.J., Kagey, M.H., Young, R.A., 2008. Tcf3 is an
integral component of the core regulatory circuitry of embryonic stem cells.
Genes Dev. 22, 746.
Davies, O.R., Lin, C.Y., Radzisheuskaya, A., Zhou, X., Taube, J., Blin, G., Waterhouse, A.,
Smith, A.J., Lowell, S., 2013. Tcf15 primes pluripotent cells for differentiation.
Cell Rep 3, 472–484.
Friedel, R., Plump, A., Lu, X., Spilker, K., Jolicoeur, C., Wong, K., Venkatesh, T., Yaron,
A., Hynes, M., Chen, B., Okada, A., McConnel, S., Rayburn, H., Tessier-Lavigne, M.,
2005. Gene targeting using a promoterless gene trap vector is an efﬁcient
method. Proc. Natl. Acad. Sci 102, 13188–13193.
Fujikura, J., Yamato, E., Yonemura, S., Hosoda, K., Masui, S., Nakao, K., Miyazaki, J.,
Niwa, H., 2002. Differentiation of embryonic stem cells is induced by GATA
factors. Genes Dev. 16, 784.
Hamazaki, T., Kehoe, S.M., Nakano, T., Terada, N., 2006. The Grb2/Mek pathway
represses Nanog in murine embryonic stem cells. Mol. Cell. Biol. 26,
7539–7549.
Hamilton, W.B., Kaji, K., Kunath, T., 2013. ERK2 suppresses self-renewal capacity of
embryonic stem cells, but is not required for multi-lineage commitment. PLoS
One 8, e60907.
Hayashi, K., de Sousa Lopes, S.M.C., Tang, F., Surani, M.A., 2008. Dynamic equili-
brium and heterogeneity of mouse pluripotent stem cells with distinct func-
tional and epigenetic states. Cell Stem Cell 3, 391–401.
Huyer, G., Liu, S., Kelly, J., Moffat, J., Payette, P., Kennedy, B., Tsaprailis, G., Gresser, M.
J., Ramachandran, C., 1997. Mechanism of inhibition of protein-tyrosine
phosphatases by vanadate and pervanadate. J. Biol. Chem. 272, 843–851.
Jennings, B.H., Ish-Horowicz, D., 2008. The Groucho/TLE/Grg family of transcrip-
tional co-repressors. Genome Biol. 9, 205. http://dx.doi.org/10.1186/gb-2008-9-
1-205.
Khar, A., Ali, A.M., 1987. Serum protects HeLa cells from antiestrogen effects in
culture. Eur. J. Cancer Clin. Oncol 23, 761–763.
Kobayashi, T., Mizuno, H., Imayoshi, I., Furusawa, C., Shirahige, K., Kageyama, R.,
2009. The cyclic gene Hes1 contributes to diverse differentiation responses of
embryonic stem cells. Genes Dev. 23, 1870–1875. http://dx.doi.org/10.1101/
gad.1823109.
Kunath, T., Saba-El-Leil, M.K., Almousailleakh, M., Wray, J., Meloche, S., Smith, A.,
2007. FGF stimulation of the Erk1/2 signalling cascade triggers transition of
pluripotent embryonic stem cells from self-renewal to lineage commitment.
Development 134, 2895–2902. http://dx.doi.org/10.1242/dev.02880.
Levasseur, D.N., Wang, J., Dorschner, M.O., Stamatoyannopoulos, J.A., Orkin, S.H.,
2008. Oct4 dependence of chromatin structure within the extended Nanog
locus in ES cells. Genes Dev. 22, 575–580.
Lien, W.H., Polak, L., Lin, M., Lay, K., Zheng, D., Fuchs, E., 2014. In vivo transcriptional
governance of hair follicle stem cells by canonical Wnt regulators. Nat. Cell Biol.
16, 179–190.
Liu, Y., Labosky, P., 2008. Regulation of embryonic stem cell self-renewal and
pluripotency by Foxd3. Stem Cells 26, 2475–2484. http://dx.doi.org/10.1634/
stemcells.2008-0269.
Marson, A., Levine, S.S., Cole, M.F., Frampton, G.M., Brambrink, T., Johnstone, S.,
Guenther, M.G., Johnston, W.K., Wernig, M., Newman, J., Calabrese, J.M., Dennis,
L.M., Volkert, T.L., Gupta, S., Love, J., Hannett, N., Sharp, P.A., Bartel, D.P.,
Jaenisch, R., Young, R.A., 2008. Connecting microRNA genes to the core
transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521–533.
Martello, G., Sugimoto, T., Diamanti, E., Joshi, A., Hannah, R., Ohtsuka, S., Göttgens,
B., Niwa, H., Smith, A., 2012. Esrrb is a pivotal target of the gsk3/tcf3 axis
regulating embryonic stem cell self-renewal. Cell Stem Cell 11, 491–504.
Martinez Arias, A., Brickman, J.M., 2011. Gene expression heterogeneities in
embryonic stem cell populations: origin and function. Curr. Opin. Cell Biol.
23, 650–656.
Morgani, S.M., Canham, M.A., Nichols, J., Sharov, A.A., Migueles, R.P., Ko, M.S.,
Brickman, J.M., 2013. Totipotent embryonic stem cells arise in ground-state
culture conditions. Cell Rep 3, 1945–1957.
Nichols, J., Silva, J., Roode, M., Smith, A., 2009. Suppression of Erk signalling
promotes ground state pluripotency in the mouse embryo. Development 136,
3215–3222.
Pereira, L., Yi, F., Merrill, B.J., 2006. Repression of Nanog gene transcription by Tcf3
limits embryonic stem cell self-renewal. Mol. Cell. Biol. 26, 7479–7491. http:
//dx.doi.org/10.1128/MCB.00368-06.
Ramahlo-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R.C., Melton, D.A., 2002. “
Stemness”: transcriptional proﬁling of embryonic and adult stem cells. Science
(80-), 597–600.
Sekiya, T., Zaret, K., 2007. Repression by Groucho/TLE/Grg proteins: genomic site
recruitment generates compacted chromatin in vitro and impairs activator
binding in vivo. Mol. Cell 28, 291–303. http://dx.doi.org/10.1016/j.molcel.
2007.10.002.
Sekkai, D., Gruel, G., Herry, M., Moucadel, V., Constantinescu, S., Albagli, O., Roux, D.,
Vainchenker, W., Bennaceur-Griscelli, A., 2005. Microarray analysis of LIF/Stat3
transcriptional targets in embryonic stem cells. Stem Cells 23, 1634. http://dx.
doi.org/10.1634/stemcells.2005-0182.
Shy, B.R., Wu, C.I., Khramtsova, G.F., Zhang, J.Y., Olopade, O.I., Goss, K.H., Merrill, B.J.,
2013. Regulation of Tcf7l1 DNA binding and protein stability as principal
mechanisms of Wnt/β-catenin signaling. Cell Rep 4, 1–9.
Singh, A.M., Hamazaki, T., Hankowski, K.E., Terada, N., 2007. A heterogeneous
expression pattern for Nanog in embryonic stem cells. Stem Cells 25, 2534–-
2542. http://dx.doi.org/10.1634/stemcells.2007-0126.
Swingler, T.E., Bess, K.L., Yao, J., Stifani, S., Jayaraman, P.-S., 2004. The proline-rich
homeodomain protein recruits members of the Groucho/Transducin-like
enhancer of split protein family to co-repress transcription in hematopoietic
cells. J. Biol. Chem. 279, 34938–34947. http://dx.doi.org/10.1074/jbc.M4044-
88200.
Tam, W., Lim, C.Y., Han, J., Zhang, J., Ang, Y.S., Ng, H.H., Yang, H., Lim, B., 2008. T-cell
factor 3 regulates embryonic stem cell pluripotency and self-renewal by the
transcriptional control of multiple lineage pathways. Stem Cells 26, 2019–2031.
Ten Berge, D., Kurek, D., Blauwkamp, T., Koole, W., Maas, A., Eroglu, E., Siu, R.K.,
Nusse, R., 2011. Embryonic stem cells require Wnt proteins to prevent
differentiation to epiblast stem cells. Nat. Cell Biol. 13, 1070–1075.
A.F. Laing et al. / Developmental Biology 397 (2015) 56–66 65
Wray, J., Kalkan, T., Gomez-Lopez, S., Eckardt, D., Cook, A., Kemler, R., Smith, A.,
2011. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the
pluripotency network and increases embryonic stem cell resistance to differ-
entiation. Nat. Cell Biol. 13, 838–845.
Wu, C.I., Hoffman, J.A., Shy, B.R., Ford, E.M., Fuchs, E., Nguyen, H., Merrill, B., 2012.
Function of Wnt/β-catenin in Counteracting Tcf3 Repression Through the Tcf3–
β-Catenin Interaction. …, 2118–2129.
Yao, J., Liu, Y., Lo, R., Tretjakoff, I., Peterson, A., Stifani, S., 2000. development of the
cerebral hemispheres in transgenic mice expressing the mammalian Groucho
homologue transducin-like-enhancer of split 1 in postmitotic. Dev 93, 105–115.
Yi, F., Pereira, L., Hoffman, J.A., Shy, B.R., Yuen, C.M., Liu, D.R., Merrill, B.J., 2011.
Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem
cell self-renewal. Nat. Cell Biol. 13, 762–770.
Yi, F., Pereira, L., Merrill, B.J., 2008. Tcf3 functions as a steady‐state limiter of
transcriptional programs of mouse embryonic stem cell self‐renewal. Stem
Cells 26, 1951–1960.
Ying, Q., Stavridis, M., Grifﬁths, D., Li, M., Smith, A., 2003. Conversion of embryonic
stem cells into neuroectodermal precursors in adherent monoculture. Nat.
Biotechnol. 21, 183–186.
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P.,
Smith, A., 2008. The ground state of embryonic stem cell self-renewal. Nature
453, 519–523. http://dx.doi.org/10.1038/nature06968.
Zamparini, A.L., Watts, T., Gardner, C.E., Tomlinson, S.R., Johnston, G.I., Brickman, J.
M., 2006. Hex acts with {beta}-catenin to regulate anteroposterior patterning
via a Groucho-related co-repressor and Nodal. Development 133, 3709–3722.
Zhou, X., Smith, A., Waterhouse, A., Blin, G., Malguti, M., Lin, C.Y., Osorno, R.,
Chambers, I., Lowell, S., 2013. Hes1 Desynchronizes differentiation of pluripo-
tent cells by modulating STAT3 activity. Stem Cells 31, 1511–1522.
Ziemer, A., Tietze, K., Knust, E., Campos-Ortega, J.A., 1988. Genetic analysis of
enhancer of split, a locus involved in neurogenesis in Drosophila melanogaster.
Genetics 119, 63.
A.F. Laing et al. / Developmental Biology 397 (2015) 56–6666
